Economic Aspects in the Management of Diabetic Macular Edema in Italy

BACKGROUND: Diabetic Macular Edema (DME) is the most common cause of vision loss in diabetic patients. Currently, the Vascular Endothelial Growth Factor inhibitors (anti-VEGFs) are used as the first line of DME treatment and corticosteroid implants are usually used as a second-line treatment. These...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrò, Giovanna Elisa, Basile, Michele, Varano, Monica, Amore, Filippo, Ricciardi, Roberto, Bandello, Francesco, Cicchetti, Americo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353644/
https://www.ncbi.nlm.nih.gov/pubmed/35937268
http://dx.doi.org/10.3389/fpubh.2022.938987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353644/
https://www.ncbi.nlm.nih.gov/pubmed/35937268
http://dx.doi.org/10.3389/fpubh.2022.938987

Ejemplares similares